Wright Medical Group N.v. (WMGI): Jennifer S. Walker , SVP, Process Improvement of Wright Medical Group N.v. sold 1,167 shares on Jun 2, 2016. The Insider selling transaction was reported by the company on Jun 3, 2016 to the Securities and Exchange Commission. The shares were sold at $19.34 per share for a total value of $22,566.40 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Jun 3, 2016, Terry Rich (President, Upper Extremities) sold 2,237 shares at $19.35 per share price.On Jun 3, 2016, Julie D Tracy (SVP & Chief Communic. Officer) sold 3,277 shares at $19.38 per share price.Also, On Jun 3, 2016, Jonathan Wesley Porter (SVP & Chief Compliance Officer) sold 1,735 shares at $19.34 per share price.On Jun 3, 2016, Gregory Morrison (SVP, Human Resources) sold 1,932 shares at $19.34 per share price.
Shares of Wright Medical Group Inc (WMGI) ended Friday, Jun 3, 2016 session in red amid volatile trading. The shares closed down -0.35 points or -1.78% at $19.26 with 11,78,848 shares getting traded. Post opening the session at $19.61, the shares hit an intraday low of $19.03 and an intraday high of $19.66 and the price vacillated in this range throughout the day. The company has a market cap of $1,978 M and the number of outstanding shares has been calculated to be 10,27,13,374 shares. The 52-week high of Wright Medical Group Inc is $27.01 and the 52-week low is $15.02.
Company has been under the radar of several Street Analysts.Wright Medical Group Inc is Reiterated by Needham to Buy and the brokerage firm has raised the Price Target to $ 24 from a previous price target of $22 .The Rating was issued on May 5, 2016.Wright Medical Group Inc is Upgraded by Wells Fargo to Outperform. Earlier the firm had a rating of Market Perform on the company shares. The Rating was issued on May 5, 2016.Wright Medical Group Inc is Reiterated by RBC Capital Mkts to Outperform while Lowering the Price Target of the company shares to $ 22 from a previous price target of $29 . The Rating was issued on Mar 23, 2016.
Wright Medical Group Inc. is a global specialty orthopaedic company. The Company through Wright Medical Technology Inc. (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. The Company operates through three segments: U.S. International and BioMimetic. The Company’s business includes products that are used in foot and ankle repair upper extremity products and biologics products which are used to replace damaged or diseased bone to stimulate bone growth and to provide other biological solutions for surgeons and patients. The Company’s products include extremity hardware foot and ankle hardware upper extremity hardware and biologics.